Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IFNA2 anticorps

IFNA2 Reactivité: Humain ELISA, ELISpot Hôte: Souris Monoclonal MT1 unconjugated
N° du produit ABIN6963843
  • Antigène Voir toutes IFNA2 Anticorps
    IFNA2 (Interferon, alpha 2 (IFNA2))
    Reactivité
    • 59
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 37
    • 22
    • 1
    Souris
    Clonalité
    • 39
    • 21
    Monoclonal
    Conjugué
    • 27
    • 7
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IFNA2 est non-conjugé
    Application
    • 36
    • 29
    • 15
    • 14
    • 12
    • 9
    • 9
    • 9
    • 8
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, ELISpot
    Specificité
    Native and recombinant human IFN-α subtypes 2a, 2b, 2c
    Purification
    Purified from in vitro cultures by protein G affinity chromatography.
    Stérilité
    0.2 μm filtered
    Immunogène
    Recombinant human IFN-alpha 2c
    Clone
    MT1
    Isotype
    IgG1
    Top Product
    Discover our top product IFNA2 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    supplied at 1 mg/mL in PBS with 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
    Date de péremption
    18 months
  • Hochmann, Mittermeir, Santic, Koszik, Griessner, Sonderegger, Hoffmann, Russe, Scheiblhofer, Weiss, Mandler, Schneeberger, Strunk: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." dans: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).

    Ingelsson, Söderberg, Strid, Söderberg, Bergh, Loitto, Lotfi, Segelmark, Spyrou, Rosén: "Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 3, pp. E478-E487, (2018) (PubMed).

    Chan, Feeney, Leong, McLeod, Porter, Williams, Kaminskas: "An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration." dans: Biomacromolecules, Vol. 18, Issue 9, pp. 2866-2875, (2018) (PubMed).

    Bijak, Dziedzic, Synowiec, Sliwinski, Saluk-Bijak: "Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes." dans: Nutrients, Vol. 9, Issue 9, (2018) (PubMed).

    Hansmann, Groeger, von Wulffen, Bein, Hackstein: "Human monocytes represent a competitive source of interferon-alpha in peripheral blood." dans: Clinical immunology (Orlando, Fla.), Vol. 127, Issue 2, pp. 252-64, (2008) (PubMed).

  • Antigène
    IFNA2 (Interferon, alpha 2 (IFNA2))
    Autre désignation
    IFNA2 (IFNA2 Produits)
    Synonymes
    anticorps IFN-alphaA, anticorps IFNA, anticorps IFNA2B, anticorps INFA2, anticorps Ifa2, anticorps IFNA2, anticorps interferon alpha 2, anticorps interferon, alpha 2, anticorps interferon-alpha-2, anticorps interferon alpha-2, anticorps IFNA2, anticorps Ifna2, anticorps ifna2, anticorps IFN-ALPHA2, anticorps LOC102142148
    ID gène
    3440
    Pathways
    Signalistation JAK/STAT, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
Vous êtes ici:
Support technique